Referenzinstitut für Bioanalytik Survey directors Prof. Dr. C. Knabbe Prof. Dr. Dr. K.P. Kohse Prof. Dr. M. Neumaier Head of RfB Dr. W. J. Geilenkeuser Dr. A. Kessler Bonn, 6. March 2018 Referenzinstitut für Bioanalytik - Friesdorfer Str. 153 - D-53175 Bonn Tel. 0228 / 926895 - 0 - Fax 0228 / 926895-29 - Web: www.rfb.bio - E-Mail: [email protected]Tijen Tanyalcin MD,PH Tanyalcin Tip laboratuvari Kizilkanat Sag lik Sitisi B Blok kat 1 1359 sokak no 4/3 35220 ALSANCAK, IZMIR TURKEY Survey: NBS1/18 month: February 2018 Participant-No: 9900667 date of issue: 17.02.18 17-OH-progesterone (2) This certificate is valid until the end of August 2018. The number in parentheses characterizes the analytical method used. The assignment of the number to the respective method and/or the respective instrument is to be taken from the total evaluation. Certificate http://www.rfb.bio/cgi/certificate?tnr=9900667&rv_id=NBS_181 &version=0&uuid=04F623F4B8994BC9A1E636C14E1A70B7 We confirm that you have participated in the survey for neonatal screening. You have met the requirements of the survey for the following analytes:
13
Embed
Survey: NBS1/18 February 2018 9900667 17.02.18 ... 2018_1.pdf · Survey: NBS1/18 month: February 2018 Participant-No: 9900667 Listing and Evaluation of all your results Explanations
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Tijen Tanyalcin MD,PHTanyalcin Tip laboratuvariKizilkanat Sag lik Sitisi B Blok kat 11359 sokak no 4/335220 ALSANCAK, IZMIRTURKEY
Survey: NBS1/18month: February 2018Participant-No: 9900667date of issue: 17.02.18
17-OH-progesterone (2)
This certificate is valid until the end of August 2018.
The number in parentheses characterizes the analytical method used.The assignment of the number to the respective method and/or the respective instrumentis to be taken from the total evaluation.
Certificate
http:/
/www
.rfb.b
io/cg
i/cer
tifica
te?tnr
=990
0667
&rv_
id=NB
S_18
1&v
ersio
n=0&
uuid=
04F6
23F4
B899
4BC9
A1E6
36C1
4E1A
70B7 We confirm that you have participated in the survey for neonatal screening.
You have met the requirements of the survey for the following analytes:
Tijen Tanyalcin MD,PHTanyalcin Tip laboratuvariKizilkanat Sag lik Sitisi B Blok kat 11359 sokak no 4/335220 ALSANCAK, IZMIRTURKEY
Survey: NBS1/18month: February 2018Participant-No: 9900667date of issue: 17.02.18
TSH (2) 17-OH-progesterone (2) IRT (2)
The number in parentheses characterizes the analytical method used.The assignment of the number to the respective method and/or the respective instrumentis to be taken from the total evaluation.
Participation certificateWe confirm that you have participated in the survey for neonatal screening.
The analytes determined by you are as follows:
Survey: NBS1/18month: February 2018Participant-No: 9900667
Listing and Evaluation of all your results
Explanations
CertificateA certificate is issued (given) for an analyte only if the basis for an evaluation of the accuracy is given by the guidelines of theGerman Medical Association and/or if an evaluation is possible in analogy to these guidelines (see comments on the evaluation)and, if both results for an analyte are within the given acceptance limits. (marked as '+' below C)
Certificate of participationIn the participation certificate all analytes which are included in the list on this page are listed.If all analytes are listed on the certificate no participation certificate is printed.
C M R D/Dmax T LL UL
Legend: C=Certification, M=No of method, R=your result, D=difference (R-T)Dmax= maximum allowable amount of difference in measurement, partly given byannax 1 of the guideline of the BÄK (Dt. Ärzteblatt 111, Heft 38, 19.9.2014).T = target value, either reference method value or assigned value, LL | UL = lower resp. upper limit
Certification: + = fulfilled ( quotient | D/Dmax | <= 1.0 )- = not fulfilled (quotient | D/Dmax | > 1.0± = certification cancelled because of technicaland/or analytical reasons
Other Kits: 1 77(1),2 2(1),2 9(1),3 99(1),3 247(1),4 91(1),The deviation of your result from the total median M M Muand from the median of the corresponding sub-collective (kit) Mu is: -5.5 % -37.45 %
Findings NBS1/18 -February 2018-Neonatal - Screening, TSH, Sample B
Participant No 9900667
Legend: NXMSDCVM
=====
number of resultsmean valuestandard deviationcoefficient of variationmethod number
r n
r n r n
r n r n
=
=
=
result box/result code no.
normal | CH/AGS/CF possible
CH/AGS/CF evident | other
= 16. bis 84. percentile with medianCH = congenital hypothyroidismAGS = adrenogen. syndromeCF = cystic fibrosisr n = marks your result box
3 4 5 6 7 8 9 10 11 12 13 14 15 mU/l
2222 16 3 61 5 49 6
2
20
54
51
24
18
10
31
13
4
36
59
45
60
23
12
7
19
40
14
38
15
47
11
28
8
34
29
21
27
37
58
41
26
53
17
9
52
33
35
25
32
43
55
62
39
46
56
57
42
30
44
50
48 65
63
64
66
1
Descriptive Statistics Statistics of classifications Statistics of Implications, related to Classificationsnone new card plasma sample other
Other Kits: 1 77(1),2 2(1),2 9(1),3 99(1),3 247(1),4 91(1),The deviation of your result from the total median M M Muand from the median of the corresponding sub-collective (kit) Mu is: -64.53 % -61.29 %
Findings NBS1/18 -February 2018-Neonatal - Screening, 17-OHP, Sample A
Participant No 9900667
Legend: NXMSDCVM
=====
number of resultsmean valuestandard deviationcoefficient of variationmethod number
r n
r n r n
r n r n
=
=
=
result box/result code no.
normal | CH/AGS/CF possible
CH/AGS/CF evident | other
= 16. bis 84. percentile with medianCH = congenital hypothyroidismAGS = adrenogen. syndromeCF = cystic fibrosisr n = marks your result box
Other Kits: 2 9(1),2 99(1),3 247(1),4 91(1),4 99(1),6 99(1),The deviation of your result from the total median M M Muand from the median of the corresponding sub-collective (kit) Mu is:
Findings NBS1/18 -February 2018-Neonatal - Screening, 17-OHP, Sample B
Participant No 9900667
Legend: NXMSDCVM
=====
number of resultsmean valuestandard deviationcoefficient of variationmethod number
r n
r n r n
r n r n
=
=
=
result box/result code no.
normal | CH/AGS/CF possible
CH/AGS/CF evident | other
= 16. bis 84. percentile with medianCH = congenital hypothyroidismAGS = adrenogen. syndromeCF = cystic fibrosisr n = marks your result box
14 17 20 23 26 29 32 35 38 41 44 47 50 nmol/l
51 24
21
37
42
36
56
58
64
14
39
67
1
44
46
45
31
3
15
4
16
27
69
25
38
18
60
40
41
23
59
2222
57
54
33
61
34
10
8
28
68
66
70
12
11
17
5
53
9
50
62 71 63 55
Descriptive Statistics Statistics of classifications Statistics of Implications, related to Classificationsnone new card plasma sample other
Other Kits: 2 9(1),2 99(1),3 247(1),4 91(1),4 99(1),6 99(1),The deviation of your result from the total median M M Muand from the median of the corresponding sub-collective (kit) Mu is:
Findings NBS1/18 -February 2018-Neonatal - Screening, IRT, Sample A
Participant No 9900667
Legend: NXMSDCVM
=====
number of resultsmean valuestandard deviationcoefficient of variationmethod number
r n
r n r n
r n r n
=
=
=
result box/result code no.
normal | CH/AGS/CF possible
CH/AGS/CF evident | other
= 16. bis 84. percentile with medianCH = congenital hypothyroidismAGS = adrenogen. syndromeCF = cystic fibrosisr n = marks your result box
7 9 11 13 15 17 19 21 23 25 27 29 31 µg/l
4
2
47
29
40
19
28
10
5
50
14
27
35
55
53
3
1
33
17
72
18
20
15
31
36
8
25
41
21
38
11
57
45
24
39
44
46 2222 64 51 63 48 65
Descriptive Statistics Statistics of classifications Statistics of Implications, related to Classificationsnone new card plasma sample other
Other Kits: 2 9(1),3 247(1),3 350(1),4 91(1),The deviation of your result from the total median M M Muand from the median of the corresponding sub-collective (kit) Mu is: 65 % -35.04 %
Findings NBS1/18 -February 2018-Neonatal - Screening, IRT, Sample B
Participant No 9900667
Legend: NXMSDCVM
=====
number of resultsmean valuestandard deviationcoefficient of variationmethod number
r n
r n r n
r n r n
=
=
=
result box/result code no.
normal | CH/AGS/CF possible
CH/AGS/CF evident | other
= 16. bis 84. percentile with medianCH = congenital hypothyroidismAGS = adrenogen. syndromeCF = cystic fibrosisr n = marks your result box
16 22 28 34 40 46 52 58 64 70 76 82 88 µg/l
55 28
2
18
29
35
19
47
11
4
40
25
14
1
10
53
36
31
5
20
3
72
57
41
15
33
24
64
50
27
8
44
45
38
17
21
39
51
2222 46 63 48 65
Descriptive Statistics Statistics of classifications Statistics of Implications, related to Classificationsnone new card plasma sample other
Other Kits: 2 9(1),3 247(1),3 350(1),4 91(1),The deviation of your result from the total median M M Muand from the median of the corresponding sub-collective (kit) Mu is: 60 % -29.97 %
Findings NBS1/18 -February 2018-Neonatal - Screening, PAP, Sample A
Participant No 9900667
Legend: NXMSDCVM
=====
number of resultsmean valuestandard deviationcoefficient of variationmethod number
r n
r n r n
r n r n
=
=
=
result box/result code no.
normal | CH/AGS/CF possible
CH/AGS/CF evident | other
= 16. bis 84. percentile with medianCH = congenital hypothyroidismAGS = adrenogen. syndromeCF = cystic fibrosisr n = marks your result box